calendar
29,125 catalysts · 9,622 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall
29,125 catalysts · 9,622 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: LUNDBECK PHARMS LLC. Form: FOR SOLUTION. Route: ORAL
Sponsor: AUCTA. Form: FOR SOLUTION. Route: ORAL
Sponsor: INVAGEN PHARMS. Form: FOR SOLUTION. Route: ORAL
Sponsor: GRANULES. Form: FOR SOLUTION. Route: ORAL
Sponsor: RISING. Form: CAPSULE. Route: ORAL
Sponsor: RISING. Form: CAPSULE. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: HARMONY. Form: TABLET. Route: ORAL
Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: BIOMARIN PHARM. Form: INJECTABLE. Route: INJECTION
Sponsor: BIOMARIN PHARM. Form: INJECTABLE. Route: INJECTION
Sponsor: BIOMARIN PHARM. Form: INJECTABLE. Route: INJECTION
Sponsor: ALKEM LABS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL
Sponsor: QUAGEN. Form: SYRUP. Route: ORAL
Sponsor: PHARMAAND. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ALEXION PHARM. Form: INJECTABLE. Route: INJECTION
Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: INSMED INC. Form: SUSPENSION, LIPOSOMAL. Route: INHALATION
Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: LUNDBECK PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: CUBIST PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: CUBIST PHARMS LLC. Form: POWDER. Route: INTRAVENOUS
Sponsor: EXELIXIS. Form: CAPSULE. Route: ORAL
Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: ASTELLAS. Form: CAPSULE. Route: ORAL